Abstract: Botulinum neurotoxins (BoNTs) are the most potent of known toxins and are listed as category A biothreat agents by the U.S. CDC. The BoNT-mediated proteolysis of SNARE proteins inhibits the exocytosis of acetylcholine into neuromuscular junctions, leading to life-threatening flaccid paralysis. Currently, the only therapy for BoNT intoxication (which results in the disease state botulism) includes experimental preventative antibodies and long-term supportive care. Therefore, there is an urgent need to identify and develop inhibitors that will serve as both prophylactic agents and post-exposure ‘rescue’ therapeutics. This review focuses on recent progress to discover and develop small molecule inhibitors as therapeutic countermeasures for BoNT intoxication.
This is an open access article distributed under the
Creative Commons Attribution License which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
Export to BibTeX
MDPI and ACS Style
Li, B.; Peet, N.P.; Butler, M.M.; Burnett, J.C.; Moir, D.T.; Bowlin, T.L. Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication. Molecules 2011, 16, 202-220.
Li B, Peet NP, Butler MM, Burnett JC, Moir DT, Bowlin TL. Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication. Molecules. 2011; 16(1):202-220.
Li, Bing; Peet, Norton P.; Butler, Michelle M.; Burnett, James C.; Moir, Donald T.; Bowlin, Terry L. 2011. "Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication." Molecules 16, no. 1: 202-220.